Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9278420rdf:typepubmed:Citationlld:pubmed
pubmed-article:9278420lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C0021757lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C0079866lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C0600115lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C1704788lld:lifeskim
pubmed-article:9278420lifeskim:mentionsumls-concept:C0684162lld:lifeskim
pubmed-article:9278420pubmed:issue36lld:pubmed
pubmed-article:9278420pubmed:dateCreated1997-10-2lld:pubmed
pubmed-article:9278420pubmed:abstractTextInterleukin-3 (IL-3) is a member of the cytokine superfamily that promotes multi-potential hematopoietic cell growth by interacting with a cell surface receptor composed of alpha and beta chains. The newly available three-dimensional structure of a variant of human (h) IL-3 allowed us to evaluate new and existing mutagenesis data and to rationally interpret the structure-function relationship of hIL-3 on a structural basis. The amino acid residues that were identified to be important for hIL-3 activity are grouped into two classes. The first class consists of largely hydrophobic residues required for the structural integrity of the protein, including the residues in IL-3 that are largely conserved among 10 mammalian species. These residues form the core of a scaffold for the second class of more rapidly diverging solvent-exposed residues, likely to be required for interaction with the receptor. Ten important and solvent-exposed residues, Asp21, Gly42, Glu43, Gln45, Asp46, Met49, Arg94, Pro96, Phe113, and Lys116, map to one side of the protein and form a putative binding site for the alpha subunit of the receptor. A model of the IL-3.IL-3 receptor complex based on the human growth hormone (hGH).hGH soluble receptor complex structure suggests that the interface between IL-3 and the IL-3 receptor alpha subunit consists of a cluster of hydrophobic residues flanked by electrostatic interactions. Although the IL-3/IL-3 receptor beta subunit interface cannot be uniquely located due to the lack of sufficient experimental data, several residues of the beta subunit that may interact with Glu22 of IL-3 are proposed. The role of these residues can be tested in future mutagenesis studies to define the interaction between IL-3 and IL-3 receptor beta subunit.lld:pubmed
pubmed-article:9278420pubmed:languageenglld:pubmed
pubmed-article:9278420pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9278420pubmed:citationSubsetIMlld:pubmed
pubmed-article:9278420pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9278420pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9278420pubmed:statusMEDLINElld:pubmed
pubmed-article:9278420pubmed:monthSeplld:pubmed
pubmed-article:9278420pubmed:issn0021-9258lld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:FengYYlld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:McKearnJ PJPlld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:HoodW FWFlld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:PairBBlld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:KleinB KBKlld:pubmed
pubmed-article:9278420pubmed:authorpubmed-author:McWherterC...lld:pubmed
pubmed-article:9278420pubmed:issnTypePrintlld:pubmed
pubmed-article:9278420pubmed:day5lld:pubmed
pubmed-article:9278420pubmed:volume272lld:pubmed
pubmed-article:9278420pubmed:ownerNLMlld:pubmed
pubmed-article:9278420pubmed:authorsCompleteYlld:pubmed
pubmed-article:9278420pubmed:pagination22630-41lld:pubmed
pubmed-article:9278420pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:meshHeadingpubmed-meshheading:9278420-...lld:pubmed
pubmed-article:9278420pubmed:year1997lld:pubmed
pubmed-article:9278420pubmed:articleTitleThe receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling.lld:pubmed
pubmed-article:9278420pubmed:affiliationG. D. Searle and Company, St. Louis, Missouri 63198, USA.lld:pubmed
pubmed-article:9278420pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3562entrezgene:pubmedpubmed-article:9278420lld:entrezgene
entrez-gene:1439entrezgene:pubmedpubmed-article:9278420lld:entrezgene
entrez-gene:3563entrezgene:pubmedpubmed-article:9278420lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9278420lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9278420lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9278420lld:pubmed